Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-024905
Filing Date
2024-10-08
Accepted
2024-10-08 19:09:08
Documents
2
Period of Report
2024-10-04

Document Format Files

Seq Description Document Type Size
1 form3-10082024_111004.html 3  
1 form3-10082024_111004.xml 3 1703
2 ex24-10082024_111005.htm EX-24 5217
  Complete submission text file 0001415889-24-024905.txt   8464
Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Issuer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ONKURE, INC. 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address
Hartley Dylan (Reporting) CIK: 0002037442 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40315 | Film No.: 241361223